Please assess the completion status of the following clinical trial:

Trial Title: Gabapentin on Postoperative Pain Associated With Ureteroscopy and Stents Insertion

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 18 years to 75 years~* Patients with obstructive kidney stones undergoing elective ureteroscopy or cystoscopy with Ureteral stent placement~Exclusion Criteria:~* Age less than 18 or more than 75 years~* Acetaminophen allergy~* Gabapentin allergy~* Hydromorphone allergy~* Chronic use of gabapentin~* History of chronic pain (Pain for \> than 3 months)~* Chronic renal insufficiency (Creatinine \> 1.3)~* Seizure disorder~* Psychiatric disorders (medically treated)~* Chronic use of anticonvulsants, antidepressants, antipsychotics (use \> 3 months)~* Antacids ingested within 2 hours prior to surgery~* History of gastric or duodenal ulcer~* Pregnant or lactating~* Inability to communicate in English

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): Placebo pill administered 1 hour before planned surgical procedure
- Gabapentin (Type: EXPERIMENTAL): Gabapentin pill (1200mg) administered orally 1 hour prior to planned surgical procedure

Based on this trial design, predict the completion outcome and termination type (if applicable).